1 reports of this reaction
2.1% of all COMFREY ROOT reports
#9 most reported adverse reaction
COMA is the #9 most commonly reported adverse reaction for COMFREY ROOT, manufactured by Boiron. There are 1 FDA adverse event reports linking COMFREY ROOT to COMA. This represents approximately 2.1% of all 47 adverse event reports for this drug.
Patients taking COMFREY ROOT who experience coma should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
COMA is a less commonly reported adverse event for COMFREY ROOT, but still significant enough to appear in the safety profile.
In addition to coma, the following adverse reactions have been reported for COMFREY ROOT:
The following drugs have also been linked to coma in FDA adverse event reports:
COMA has been reported as an adverse event in 1 FDA reports for COMFREY ROOT. This does not prove causation, but indicates an association observed in post-market surveillance data.
COMA accounts for approximately 2.1% of all adverse event reports for COMFREY ROOT, making it a notable side effect.
If you experience coma while taking COMFREY ROOT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.